NCT04889716 2026-05-26CAR-T Followed by Bispecific AntibodiesAbramson Cancer Center at Penn MedicinePhase 2 Recruiting23 enrolled
NCT07249905 2026-05-04Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting180 enrolled